Content about Alkaloids

September 28, 2012

OncoGenex starts phase-3 trial of lung cancer drug

Drug maker OncoGenex Pharmaceuticals has started its third late-stage clinical trial of a drug for treating a type of lung cancer.

September 28, 2011

Sagent's chemotherapy drug enters market

Sagent Pharmaceuticals has launched its new chemotherapy drug.

August 23, 2011

Sandoz announces FDA approval, U.S. launch of chemotherapy drug

The Food and Drug Administration has approved a chemotherapy drug made by Sandoz, the drug maker said Tuesday.

April 29, 2011

Zytiga OKed as prostate cancer treatment

The Food and Drug Administration has approved a new treatment for prostate cancer made by Johnson & Johnson.

March 10, 2011

Hospira gets OK to market generic Taxotere

Hospira has received approval from the Food and Drug Administration for a generic cancer treatment.

January 6, 2011

AdventRx's application for Exelbine accepted by FDA

The Food and Drug Administration has accepted the approval application for a chemotherapy drug to treat lung cancer from AdventRx Pharmaceuticals, the drug maker said Thursday.

December 8, 2010

Decision Resources: J&J, Merck chemotherapy drugs will emerge as go-to second-line treatments

Chemotherapy drugs made by Johnson & Johnson and Merck will become the standard second-line treatment for ovarian cancer within the decade, replacing a treatment made by Bristol-Myers Squibb and generic versions, according to a new report by market research firm Decision Resources.

September 30, 2010

FDA has eye on companies that sell oral colchicine

The Food and Drug Administration is cracking down on companies that sell an unapproved treatment...

September 30, 2010

Study: Jevtana combined with Novantrone reduced death risk in prostate cancer patients

Data published in the latest issue of medical journal The Lancet showed that a recently...